neon ion radiotherapy possesses biologic physical advantages megavoltage x rays biologically neon beam reduces oxygen enhancement ratio increases relative biological effectiveness cells irradiated neon ions variation related radiosensitivity decreased repair radiation injury physical behavior heavy charged particles allows precise delivery high radiation doses tumors minimizing irradiation normal tissues NUMBER phase clinical trial started lawrence berkeley laboratory using neon ions irradiate patients conventional treatment modalities ineffective end NUMBER total NUMBER patients received minimum neon physical dose NUMBER cgy median survivors NUMBER months compared historical results actuarial survival dss5 local control lc5 rates suggest neon treatment improves outcome types tumors advanced recurrent macroscopic salivary gland carcinomas dss5 NUMBER lc5 NUMBER b paranasal sinus tumors dss5 NUMBER lc5 NUMBER macroscopic disease c advanced soft tissue sarcomas dss5 NUMBER lc5 NUMBER macroscopic disease d macroscopic sarcomas bone dss5 NUMBER lc5 NUMBER e locally advanced prostate carcinomas dss5 NUMBER lc5 NUMBER f biliary tract carcinomas dss5 NUMBER lc5 NUMBER treatment malignant gliomas pancreatic gastric esophageal lung advanced recurrent head neck cancer successful results tumors appear better achieved conventional therapy findings suggest phase iii trials using neon beam implemented selected malignancies cell cycle ii follow NUMBER year disease specific x ray